These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18940292)

  • 41. Ezetimibe effectively decreases LDL-cholesterol in HIV-infected patients.
    Coll B; Aragonés G; Parra S; Alonso-Villaverde C; Masana L
    AIDS; 2006 Aug; 20(12):1675-7. PubMed ID: 16868453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cholesterol resorption inhibition prevents high statin doses. Lipid lowering in double-pack].
    MMW Fortschr Med; 2002 Nov; 144(48):60. PubMed ID: 12532550
    [No Abstract]   [Full Text] [Related]  

  • 43. Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease.
    Nag SS; Pearson TA; Ma L; Landsman PB; Cimino A; Vickers FF; Alexander CM; Melin JM
    Am J Cardiol; 2005 Apr; 95(7):862-4. PubMed ID: 15781017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of ezetimibe in the management of patients with atherosclerosis.
    Hamilton P
    Coron Artery Dis; 2009 Mar; 20(2):169-74. PubMed ID: 19106797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
    Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
    Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of ezetimibe monotherapy in 1624 primary hypercholesterolaemic patients for up to 2 years.
    Dujovne CA; Suresh R; McCrary Sisk C; Maccubbin D; Strony J; Veltri E
    Int J Clin Pract; 2008 Sep; 62(9):1332-6. PubMed ID: 18564342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
    Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
    Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statin and ezetimibe combination therapy in cardiovascular disease.
    Dembowski E; Davidson MH
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):183-8. PubMed ID: 19262375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ezetimibe treatment in hypercholesterolemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study.
    Türk TR; Voropaeva E; Kohnle M; Nürnberger J; Philipp T; Kribben A; Heemann U; Witzke O
    Nephrol Dial Transplant; 2008 Jan; 23(1):369-73. PubMed ID: 17956887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical experience with ezetimibe/simvastatin in a Mediterranean population.
    Migdalis I; Efthimiadis A; Pappas S; Alexopoulos D; Vlasserou F; Mikhailidis DP
    Curr Med Res Opin; 2009 Oct; 25(10):2571-6. PubMed ID: 19739939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
    Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM
    Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
    Corsini A; Windler E; Farnier M
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Achieving cholesterol goals. Current and future drug therapies.
    Jones PH
    Postgrad Med; 2003 Aug; 114(2 Suppl):14-21. PubMed ID: 19667635
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients.
    Huang CF; Li TC; Lin CC; Liu CS; Shih HC; Lai MM
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):438-40. PubMed ID: 17568245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cholesterol reduction using psyllium husks - do gastrointestinal adverse effects limit compliance? Results of a specific observational study.
    Uehleke B; Ortiz M; Stange R
    Phytomedicine; 2008 Mar; 15(3):153-9. PubMed ID: 18222665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ezetimibe lowers cholesterol levels.
    Proj Inf Perspect; 2009 Mar; (48):13. PubMed ID: 19492464
    [No Abstract]   [Full Text] [Related]  

  • 57. The efficacy and tolerability of ezetimibe in cardiac transplant recipients taking cyclosporin.
    Shaw SM; Chaggar P; Ritchie J; Shah MK; Baynes AC; O'Neill N; Fildes JE; Yonan N; Williams SG
    Transplantation; 2009 Mar; 87(5):771-5. PubMed ID: 19295325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ODYSSEY MONO: effect of alirocumab 75 mg subcutaneously every 2 weeks as monotherapy versus ezetimibe over 24 weeks.
    Roth EM; McKenney JM
    Future Cardiol; 2015; 11(1):27-37. PubMed ID: 25606700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined effects of ezetimibe and phytosterols on cholesterol metabolism: a randomized, controlled feeding study in humans.
    Lin X; Racette SB; Lefevre M; Ma L; Spearie CA; Steger-May K; Ostlund RE
    Circulation; 2011 Aug; 124(5):596-601. PubMed ID: 21768544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypercholesterolemic effect of Chinese black tea extract in human subjects with borderline hypercholesterolemia.
    Fujita H; Yamagami T
    Nutr Res; 2008 Jul; 28(7):450-6. PubMed ID: 19083445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.